A Phase 2A Partially-blind Placebo Controlled Trial to Evaluate the Safety and Immunogenicity of Live Attenuated, Intranasal B. Pertussis Vaccine (BPZE1) in Healthy Adults

Trial Profile

A Phase 2A Partially-blind Placebo Controlled Trial to Evaluate the Safety and Immunogenicity of Live Attenuated, Intranasal B. Pertussis Vaccine (BPZE1) in Healthy Adults

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 10 Aug 2018

At a glance

  • Drugs BPZE 1 (Primary)
  • Indications Pertussis
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Aug 2018 Planned initiation date changed from 26 Jul 2018 to 3 Aug 2018.
    • 05 Jul 2018 Planned initiation date changed from 30 Jun 2018 to 26 Jul 2018.
    • 17 May 2018 Status changed from planning to not yet recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top